Literature DB >> 8985102

Transformation of normal human fibroblasts into immortalized cells with the mutant p53 gene and X-rays.

K Fushimi1, M Iijima, C Gao, T Kondo, T Tsuji, T Hashimoto, K Mihara, M Namba.   

Abstract

In vitro cell transformation is a valuable approach for studying the mechanisms of multistep carcinogenesis of human cells. Since immortalization is an essential step for in vitro neoplastic transformation of human cells, this study addresses the question of whether mutant p53 contributes to the immortalization process of human cells. The mutant p53 gene (mp53: codon273Arg-His) was introduced into normal human fibroblasts (OUMS-24 line) and a G418-resistant clone, OUMS-24/P6 line, was obtained. This clone showed an extended life span and chromosome abnormalities, but senesced at the 79th population doubling level (PDL). When these cells were subjected to intermittent X-ray treatment, they became an immortalized cell line (OUMS-24/P6X). Although these immortalized cells showed chromosome abnormalities, they were not tumorigenic. On the other hand, normal OUMS-24 cells into which mp53 had not been introduced were not immortalized by the same X-ray treatment. These results indicate that introduction and expression of mp53 alone were not sufficient for immortalization of human cells, and that mutations of the remaining wild-type p53 or other genes may have been necessary for immortalization. In fact, no expression of the wild-type p53 was detected in the immortalized cells by RT-PCR. Expression of p21, which is located downstream of p53, was remarkably reduced in the immortalized cells, resulting in an increase in cdk2 and cdc2 kinase activity. These findings indicate that the p53-p21 cascade may play some role in the immortalization of human cells. On the other hand, there was no significant difference in expression of proteins such as Rb, p16, cdk4, cdk6, cyclin A and cyclin D1 between the normal and immortalized human fibroblasts.

Entities:  

Mesh:

Year:  1997        PMID: 8985102     DOI: 10.1002/(sici)1097-0215(19970106)70:1<135::aid-ijc20>3.0.co;2-j

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  4 in total

1.  Immortalization of mutant p53-transfected human fibroblasts by treatment with either 4-nitroquinoline 1-oxide or X-rays.

Authors:  K Kino; K Fushimi; C Gao; T Shima; K Mihara; M Namba
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-09       Impact factor: 2.416

2.  Combination of adenoviruses expressing melanoma differentiation-associated gene-7 and chemotherapeutic agents produces enhanced cytotoxicity on esophageal carcinoma.

Authors:  G Ma; K Kawamura; Y Shan; S Okamoto; Q Li; M Namba; M Shingyoji; Y Tada; K Tatsumi; K Hiroshima; H Shimada; M Tagawa
Journal:  Cancer Gene Ther       Date:  2014-01-17       Impact factor: 5.987

3.  Adenoviruses-mediated transduction of human oesophageal carcinoma cells with the interferon-λ genes produced anti-tumour effects.

Authors:  Q Li; K Kawamura; S Okamoto; H Fujie; M Numasaki; M Namba; M Nagata; H Shimada; H Kobayashi; M Tagawa
Journal:  Br J Cancer       Date:  2011-09-27       Impact factor: 7.640

4.  Mesenchymal stem cells are efficiently transduced with adenoviruses bearing type 35-derived fibers and the transduced cells with the IL-28A gene produces cytotoxicity to lung carcinoma cells co-cultured.

Authors:  Takeo Suzuki; Kiyoko Kawamura; Quanhai Li; Shinya Okamoto; Yuji Tada; Koichiro Tatsumi; Hideaki Shimada; Kenzo Hiroshima; Naoto Yamaguchi; Masatoshi Tagawa
Journal:  BMC Cancer       Date:  2014-09-25       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.